These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27598556)

  • 21. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.
    Van Duong T; Van den Mooter G
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1681-1694. PubMed ID: 27267583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles.
    Askin S; Zhao M; Gonçalves AD; Gaisford S; Craig DQM
    Mol Pharm; 2018 Aug; 15(8):3332-3342. PubMed ID: 29933697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in Supersaturation and Phase Behavior of Ezetimibe Amorphous Solid Dispersions upon Dissolution in Different Biorelevant Media.
    Elkhabaz A; Sarkar S; Dinh JK; Simpson GJ; Taylor LS
    Mol Pharm; 2018 Jan; 15(1):193-206. PubMed ID: 29161509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
    J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2019 Jan; 16(1):448-461. PubMed ID: 30521350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
    Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
    Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and dynamic properties of amorphous solid dispersions: the role of solid-state nuclear magnetic resonance spectroscopy and relaxometry.
    Paudel A; Geppi M; Mooter GVD
    J Pharm Sci; 2014 Sep; 103(9):2635-2662. PubMed ID: 24715618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.
    Indulkar AS; Gao Y; Raina SA; Zhang GG; Taylor LS
    Mol Pharm; 2016 Jun; 13(6):2059-69. PubMed ID: 27138900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs.
    Raina SA; Zhang GGZ; Alonzo DE; Wu J; Zhu D; Catron ND; Gao Y; Taylor LS
    J Pharm Sci; 2014 Sep; 103(9):2736-2748. PubMed ID: 24382592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic understanding of the phase behavior of supersaturated solutions of poorly water-soluble drugs.
    Tres F; Posada MM; Hall SD; Mohutsky MA; Taylor LS
    Int J Pharm; 2018 May; 543(1-2):29-37. PubMed ID: 29572154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
    Sarode AL; Wang P; Obara S; Worthen DR
    Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.